ICIG Completes Acquisition of Sandoz Industrial Products GmbH
Sandoz Industrial Products GmbH will be renamed Corden BioChem and will be associated with the CordenPharma Group, ICIG’s pharmaceutical platform.
On April 1, 2016, International Chemical Investors Group (ICIG) announced the completion of its acquisition of Sandoz Industrial Products GmbH, a Frankfurt-Höchst-based manufacturer of enzyme fermentation products and intermediates for the pharmaceutical industry, from Novartis Group.
Sandoz Industrial Products will be renamed Corden BioChem GmbH and will be associated with the CordenPharma Group, the pharmaceutical platform of ICIG. Corden BioChem will be complementary to ICIG’s pharma activities as well as to its fine chemicals activities within the WeylChem Group. According to a press announcement, ICIG is focused on the development of Corden BioChem with the enzymatic 7-ACA businesses for antibiotics applications at the Höchst site as well as the CordenPharma Latina site in Italy.
Source: ICIG
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Drug Solutions Podcast: Emerging Methods of Vaccine Administration and Distribution
June 20th 2023Michael Schrader, CEO and co-founder of Vaxess, discusses the latest on vaccine administration and different ways the pharmaceutical industry can distribute these products with Pharmaceutical Technology editor Jill Murphy.
